Streetbeat News

Products Services

CART

GME

RDDT

Reddit Inc (NYSE:RDDT) has seen a surge in bullish options activity since its IPO, with shares climbing significantly. Despite no annual profit since 2005, investor interest remains high, with a focus on call options. Opinions among investors vary, with some skeptical of Reddit's financials and future growth. Comparisons with other IPOs like Instacart (NASDAQ:CART) suggest Reddit's valuation may be more reasonable. The debate between bullish and bearish sentiments continues, with high options premiums indicating uncertainty about Reddit's future.

Portfolio Pulse from Surbhi Jain

March 26, 2024 | 12:39 pm

MARA

Marathon Digital Holdings, Inc. (NASDAQ:MARA) announced the MARA 2PIC700, a next-generation two-phase immersion cooling system designed to enhance data center operations. This system promises to increase power density by 2-4 times, reduce space requirements by up to 75%, and significantly lower cooling costs for Bitcoin mining. It's built for remote management, enabling operations in extreme climates. The technology, showcasing at the Empower Conference in Houston, is part of Marathon's strategy to vertically integrate its tech stack and diversify operations, potentially benefiting various industries.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 12:37 pm

AAPL

Apple Inc. is preparing significant updates for iOS 18, including a redesigned home screen and enhanced AI features, to be announced at the Worldwide Developers Conference (WWDC) in June. The update aims to provide more flexibility in home screen customization and integrate AI-powered features across the operating system, potentially including chatbot functionality through Google Gemini. Other updates for iPadOS 18, watchOS 11, visionOS 2, and macOS are also expected, with developer betas in June and a public release in September.

Portfolio Pulse from Rounak Jain

March 26, 2024 | 12:36 pm

TELO

Telomir Pharmaceuticals has partnered with Argenta to conduct a study on the efficacy of Telomir-1 in treating osteoarthritis and other age-related diseases in canines. This groundbreaking study aims to explore the potential of reversing aging in dogs.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:35 pm

OMQS

OMNIQ Corp. (OMQS) received a purchase order to supply ruggedized lot equipment for Nestle's advanced logistic center in Israel. This order adds to OMNIQ's portfolio of clients, including SPAR and a major U.S. sporting goods chain, highlighting its growing presence in logistic management solutions.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:34 pm

ENTX

Entera Bio Ltd. (NASDAQ:ENTX) announced the FDA's plan to rule within 10 months on using bone mineral density (BMD) as a surrogate endpoint for osteoporosis drug trials. This decision could benefit Entera's EB613, a first-in-class oral treatment for osteoporosis, currently in Phase 3, designed to meet the BMD thresholds proposed by the SABRE project. The approval of BMD as a surrogate endpoint could streamline the approval process for new osteoporosis treatments, addressing a significant treatment gap in a disease affecting over 200 million women globally.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 12:33 pm

KULR

LMT

KULR Technology Group Inc. has entered into a six-figure contract with Lockheed Martin to develop phase change material heat sinks, a significant development in thermal management solutions. This partnership highlights KULR's expertise and innovation in the field, potentially setting a precedent for future collaborations and technological advancements.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:33 pm

YTEN

Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced that its genome-edited E3902 Camelina has been cleared for planting in Canada by the Plant Biosafety Office of the Canadian Food Inspection Agency. This decision is based on the determination that E3902 is not a Plant with Novel Trait and is not subject to pre-market notification. E3902 Camelina, which has genome edits resulting in a 5% increase in oil production and a lighter seed coat color, has also received favorable regulatory determinations in the United States, Argentina, and Chile. Yield10 plans to continue its development and regulatory programs to provide new Camelina varieties to growers.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:32 pm

INZY

Inozyme Pharma announced it will report topline data from its ongoing Phase 1/2 trials of INZ-701 for treating ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024. A conference call and webcast with key opinion leaders will be hosted on the same day.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:31 pm

CERS

Cerus Corporation (NASDAQ:CERS) announced FDA approval for a 12-month shelf life for INTERCEPT Platelet Processing Sets, doubling the previous 6-month shelf life. This extension applies to all sizes of the sets in the U.S., effective immediately. The extension is expected to benefit supply chains and reduce product expiration risk. Cerus is also pursuing further extensions beyond 12 months.

Portfolio Pulse from Benzinga Newsdesk

March 26, 2024 | 12:31 pm